No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized* / administration & dosage
-
Antibodies, Monoclonal, Humanized* / adverse effects
-
Antineoplastic Agents, Immunological / administration & dosage
-
Antineoplastic Agents, Immunological / adverse effects
-
Antirheumatic Agents / administration & dosage*
-
Arthritis* / diagnosis
-
Arthritis* / drug therapy
-
Arthritis* / etiology
-
Arthritis* / immunology
-
Autoimmune Diseases / chemically induced
-
Autoimmune Diseases / diagnosis
-
Autoimmune Diseases / physiopathology
-
Autoimmunity / drug effects*
-
Autoimmunity / immunology
-
Drug Monitoring / methods
-
Female
-
Humans
-
Immunotherapy / adverse effects
-
Immunotherapy / methods
-
Medication Therapy Management
-
Melanoma* / drug therapy
-
Melanoma* / pathology
-
Middle Aged
-
Neoplasm Staging
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
Antirheumatic Agents
-
Programmed Cell Death 1 Receptor
-
pembrolizumab